Base
Notice2026-067282026-04-07

World Trade Center Health Program; Petitions 029, 034, 035, and 062-Hepatic Steatosis; Finding of Insufficient Evidence

Health and Human Services Department, Centers for Disease Control and Prevention

Abstract

The Administrator of the World Trade Center (WTC) Health Program has received several petitions (Petitions 029, 034, 035, and 062) to add "hepatic steatosis" or "fatty liver disease" to the List of WTC-Related Health Conditions. Upon reviewing the scientific and medical literature, including information provided by the petitioners, the Administrator has determined that there is insufficient evidence available to support taking further action at this time regarding hepatic steatosis. The Administrator also finds that insufficient evidence exists to request a recommendation of the WTC Health Program Scientific/Technical Advisory Committee, publish a proposed rule, or publish a determination not to publish a proposed rule.

Action & Dates

Action
Denial of petition for addition of a health condition.
Dates
The Administrator of the WTC Health Program is denying these petitions for the addition of a health condition as of April 7, 2026.

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Centers for Disease Control and Prevention [NIOSH Docket 094] AGENCY: Centers for Disease Control and Prevention, Department of Health and Human Services. ACTION: Denial of petition for addition of a health condition. SUMMARY: The Administrator of the World Trade Center (WTC) Health Program has received several petitions (Petitions 029, 034, 035, and 062) to add “hepatic steatosis” or “fatty liver disease” to the List of WTC-Related Health Conditions. Upon reviewing the scientific and medical literature, including information provided by the petitioners, the Administrator has determined that there is insufficient evidence available to support taking further action at this time regarding hepatic steatosis. The Administrator also finds that insufficient evidence exists to request a recommendation of the WTC Health Program Scientific/Technical Advisory Committee, publish a proposed rule, or publish a determination not to publish a proposed rule. DATES: The Administrator of the WTC Health Program is denying these petitions for the addition of a health condition as of April 7, 2026. ADDRESSES: Visit the WTC Health Program website at https://www.cdc.gov/​wtc/​received.html to review Petitions 029, 034, 035, and 062. FOR FURTHER INFORMATION CONTACT: Rachel Weiss, Program Analyst, 1090 Tusculum Avenue, MS: C-48, Cincinnati, OH 45226; telephone (404) 498-2500 (this is not a toll-free number); email NIOSHregs@c

Read full document on FederalRegister.gov →

Related Documents

Other Federal Register documents from the same docket.

Full Document

Citation: 91 FR 17650